
Intellectual Property and Competition
Michael A. Carrier(Editor)
Edward Elgar Publishing
Published on 31. March 2011
Book
Hardback
776 pages
978-1-84844-218-4 (ISBN)
Description
The intersection of the intellectual property and competition laws presents uniquely complicated legal issues. The entries, from leading judges, government officials, academics, and economists, explore history, the 'new economy', and frameworks to resolve the tension between the laws. They also address refusals to license, patent pools, innovation markets, standard setting organizations, and pharmaceutical patent settlements.
Reviews / Votes
'. . . Carrier has provided intellectual property and competition scholars and practitioners with an invaluable resource.'More details
Series
Language
English
Place of publication
Cheltenham
United Kingdom
Target group
Professional and scholarly
Dimensions
Height: 244 mm
Width: 169 mm
ISBN-13
978-1-84844-218-4 (9781848442184)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Person
Edited by Michael A. Carrier, Board of Governors Professor, Rutgers Law School, Co-Director, Rutgers Institute for Information Policy and Law, New Jersey, USA
Content
Contents:
Acknowledgements
Introduction Michael A. Carrier
PART I HISTORY
1. Herbert Hovenkamp (2005), 'The Conflict Between Antitrust and Intellectual Property Rights'
PART II NEW ECONOMY
2. Richard A. Posner (2001), 'Exclusionary Practices (II): The New Economy'
3. Robert Pitofsky (2001), 'Antitrust and Intellectual Property: Unresolved Issues at the Heart of the New Economy'
PART III GLOBAL APPROACHES
4. William F. Baxter (1966), 'Legal Restrictions on Exploitation of the Patent Monopoly: An Economic Analysis'
5. Ward S. Bowman, Jr. (1973), 'The Compatibility of Antitrust and Patent Law Goals'
6. Louis Kaplow (1984), 'The Patent-Antitrust Intersection: A Reappraisal'
7. Michael A. Carrier (2002), 'Unraveling the Patent-Antitrust Paradox'
PART IV SPECIFIC ACTIVITY
8. Herbert Hovenkamp, Mark D. Janis and Mark A. Lemley (2006), 'Unilateral Refusals to License'
9. Carl Shapiro (2000), 'Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting'
10. Robert P. Merges (2001), 'Institutions for Intellectual Property Transactions: The Case of Patent Pools'
11. Michael A. Carrier (2008), 'Two Puzzles Resolved: Of The Schumpeter - Arrow Stalemate and Pharmaceutical Innovation Markets'
12. Arti K. Rai (2001), 'Fostering Cumulative Innovation in the Biopharmaceutical Industry: The Role of Patents and Antitrust'
13. Mark A. Lemley (2002), 'Intellectual Property Rights and Standard-Setting Organizations'
14. C. Scott Hemphill (2006), 'Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem'
Acknowledgements
Introduction Michael A. Carrier
PART I HISTORY
1. Herbert Hovenkamp (2005), 'The Conflict Between Antitrust and Intellectual Property Rights'
PART II NEW ECONOMY
2. Richard A. Posner (2001), 'Exclusionary Practices (II): The New Economy'
3. Robert Pitofsky (2001), 'Antitrust and Intellectual Property: Unresolved Issues at the Heart of the New Economy'
PART III GLOBAL APPROACHES
4. William F. Baxter (1966), 'Legal Restrictions on Exploitation of the Patent Monopoly: An Economic Analysis'
5. Ward S. Bowman, Jr. (1973), 'The Compatibility of Antitrust and Patent Law Goals'
6. Louis Kaplow (1984), 'The Patent-Antitrust Intersection: A Reappraisal'
7. Michael A. Carrier (2002), 'Unraveling the Patent-Antitrust Paradox'
PART IV SPECIFIC ACTIVITY
8. Herbert Hovenkamp, Mark D. Janis and Mark A. Lemley (2006), 'Unilateral Refusals to License'
9. Carl Shapiro (2000), 'Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting'
10. Robert P. Merges (2001), 'Institutions for Intellectual Property Transactions: The Case of Patent Pools'
11. Michael A. Carrier (2008), 'Two Puzzles Resolved: Of The Schumpeter - Arrow Stalemate and Pharmaceutical Innovation Markets'
12. Arti K. Rai (2001), 'Fostering Cumulative Innovation in the Biopharmaceutical Industry: The Role of Patents and Antitrust'
13. Mark A. Lemley (2002), 'Intellectual Property Rights and Standard-Setting Organizations'
14. C. Scott Hemphill (2006), 'Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem'